Seung Woo Chung Selected Research

Seung Woo Chung Research Topics

Disease

33	Neoplasms (Cancer) 10/2022 - 06/2009
3	Triple Negative Breast Neoplasms 10/2022 - 01/2019
3	Neoplasm Metastasis (Metastasis) 01/2022 - 06/2009
3	Breast Neoplasms (Breast Cancer) 11/2021 - 06/2009
3	Hypoxia (Hypoxemia) 01/2021 - 07/2015
1	Glaucoma 05/2023
1	Fibrosis (Cirrhosis) 05/2023
1	Foreign-Body Reaction 05/2023
1	Colorectal Neoplasms (Colorectal Cancer) 10/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2017
1	Lymphatic Metastasis 09/2017
1	Body Weight (Weight, Body) 08/2016
1	Lung Neoplasms (Lung Cancer) 02/2015
1	Polyps 10/2014
1	Inflammation (Inflammations) 10/2014
1	Carcinogenesis 10/2014
1	Venous Thromboembolism 12/2012
1	Hemorrhage 06/2009

Drug/Important Bio-Agent (IBA)

9	Angiogenesis InhibitorsIBA 04/2016 - 11/2012
7	Caspase 3 (Caspase-3)IBA 10/2022 - 01/2016
7	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2022 - 06/2009
7	Heparin (Liquaemin)FDA LinkGeneric 09/2017 - 06/2009
6	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 11/2017
6	ProdrugsIBA 01/2019 - 08/2015
5	Taurocholic Acid (Sodium Taurocholate)IBA 09/2014 - 06/2012
4	Peptides (Polypeptides)IBA 10/2022 - 10/2021
4	AlbuminsIBA 10/2022 - 01/2016
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022 - 11/2012
4	Cytotoxins (Cytolysins)IBA 01/2022 - 07/2018
4	AnticoagulantsIBA 01/2021 - 06/2009
3	IntegrinsIBA 01/2022 - 11/2012
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2016
3	Therapeutic UsesIBA 01/2016 - 06/2009
2	Biocompatible Materials (Biomaterials)IBA 05/2023 - 01/2022
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 04/2016
2	LigandsIBA 10/2021 - 01/2019
2	CaspasesIBA 10/2021 - 01/2016
2	Ferritins (Ferritin)IBA 10/2021 - 01/2019
2	Protamines (Protamine Sulfate)FDA Link 10/2021 - 01/2015
2	Celecoxib (Celebrex)FDA Link 07/2015 - 10/2014
1	Guanine Nucleotide Dissociation Inhibitors (GDIs)IBA 05/2023
1	GlycosaminoglycansIBA 01/2022
1	AnthracyclinesIBA 01/2022
1	AcidsIBA 01/2022
1	Cyclin D3IBA 11/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2021
1	P-SelectinIBA 01/2021
1	CytokinesIBA 01/2021
1	SolutionsIBA 01/2019
1	monomethyl auristatin EIBA 01/2019
1	Ethylene Glycol (Monoethylene Glycol)IBA 01/2019
1	maleimideIBA 01/2019
1	MK-8776IBA 11/2018
1	Deoxycholic Acid (Sodium Deoxycholate)IBA 10/2017
1	Carboplatin (JM8)FDA LinkGeneric 10/2017
1	Vascular Endothelial Growth Factor CIBA 09/2017
1	PrionsIBA 04/2016
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 07/2015
1	PolyelectrolytesIBA 01/2015
1	CollagenIBA 01/2015
1	graphene oxideIBA 09/2014
1	cRGD-LHT7IBA 11/2012
1	Histone Deacetylase InhibitorsIBA 06/2012
1	Vorinostat FDA Link 06/2012

Therapy/Procedure

20	Therapeutics 10/2022 - 12/2012
8	Drug Therapy (Chemotherapy) 01/2022 - 10/2017
6	Radiotherapy 01/2022 - 08/2015
3	Immunotherapy 12/2021 - 01/2019
2	Chemoradiotherapy 01/2019 - 01/2019
2	Oral Administration 11/2017 - 02/2015
2	Chemoprevention 02/2015 - 10/2014
2	Intravenous Administration 09/2014 - 06/2012
1	Glaucoma Drainage Implants 05/2023
1	Injections 10/2017
1	Intravenous Infusions 08/2016